Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chongqing Xishan Science and Technology Co (SHSE:688576) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Chongqing Xishan Science and Technology Co EBITDA Margin % Related Terms
Chongqing Xishan Science and Technology Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Xishan Science and Technology Co EBITDA Margin % Chart
Chongqing Xishan Science and Technology Co Annual Data
SHSE:688576 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Chongqing Xishan Science and Technology Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chongqing Xishan Science and Technology Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Chongqing Xishan Science and Technology Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Chongqing Xishan Science and Technology Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Xishan Science and Technology Co (SHSE:688576) has a EBITDA Margin % of 7.49% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Chongqing Xishan Science and Technology Co and its competitors. This is 59% below median its historical median of 18.45. According to the industry distribution chart, Chongqing Xishan Science and Technology Co ranks #348 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 42.7%.
Is Chongqing Xishan Science and Technology Co's EBITDA Margin % too high?
Chongqing Xishan Science and Technology Co's current EBITDA Margin % of 7.49% is 59% below median its 10-year median of 18.45. The Medical Devices & Instruments industry median EBITDA Margin % is 7.52. Chongqing Xishan Science and Technology Co's value of 7.49% is 0.4% below this industry median. Based on the distribution chart, Chongqing Xishan Science and Technology Co ranks #348 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Chongqing Xishan Science and Technology Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chongqing Xishan Science and Technology Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Chongqing Xishan Science and Technology Co ranks #348 out of 815 companies for EBITDA Margin %. This puts Chongqing Xishan Science and Technology Co in the upper half of its industry. The industry median EBITDA Margin % is 7.52. Chongqing Xishan Science and Technology Co's value of 7.49% is 0.4% below this benchmark. While the company's 10-year median is 18.45 vs. the industry median of 7.52, Chongqing Xishan Science and Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.52, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chongqing Xishan Science and Technology Co's current EBITDA Margin % of 7.49% is 0.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Chongqing Xishan Science and Technology Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chongqing Xishan Science and Technology Co's current EBITDA Margin % is 7.49%, which is 59% below median its own 10-year median of 18.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Xishan Science and Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co (SHSE:688576) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥53.66, compared to a current price of ¥36.33 — trading 32.3% below its estimated fair value. The current EBITDA Margin % is 7.49%, which is 59% below median its 10-year median of 18.45 and 0.4% below the Medical Devices & Instruments industry median of 7.52. Chongqing Xishan Science and Technology Co's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Chongqing Xishan Science and Technology Co (SHSE:688576), the current EBITDA Margin % is 7.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chongqing Xishan Science and Technology Co (SHSE:688576) Overvalued in 2026?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co stock appears to be undervalued.
The current stock price of ¥36.33 is trading 32.3% below its estimated GF Value™ of ¥53.66.
GuruFocus considers Chongqing Xishan Science and Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688576:
EBITDA Margin %: 7.49% (59% below median its 10-year median of 18.45)
GF Value™: ¥53.66 vs. price of ¥36.33 (32.3% below fair value)
Industry Position: 0.4% below the Medical Devices & Instruments median (#348 of 815)
No single metric tells the full story. See the SHSE:688576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chongqing Xishan Science and Technology Co Business Description
AddressNo. 9, Middle Section of Huangshan Avenue, Jupiter Science and Technology Development Center, High-tech Park, North New District, Chongqing, CHN, 401121
Chongqing Xishan Science and Technology Co Ltd focuses on surgical instruments, especially in the field of minimally invasive surgical instruments. It is mainly engaged in the research, development, production and sales of minimally invasive surgical instruments. Speculum, energy surgery equipment and other products, currently the products are mainly used in neurosurgery, ENT, orthopedics, breast surgery and other clinical departments. The company's main products are surgical power units, consumables and accessories, which are mainly used for cutting, grinding, planing, sawing, milling and trimming of bone tissue and soft tissue in surgical operations, especially minimally invasive surgical operations.
85GF Score
Get the complete analysis for SHSE:688576
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688576 has been successfully added to your 
